CoLucid Pharmaceuticals, Inc.
Funding rounds
2 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Jan 2015 | $37 M | No. 2 | $10 to $50 million | equity | SEC | |
| Jan 2009 | $9 M | No. 1 | $2 to $10 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
CoLucid Pharmaceuticals, Inc. had no revenue when it filed its newest notice of a funding round (Jan 2015).
SEC Form D (revenue range) · Jan 2015
The industry group it chose in its notices: Pharmaceuticals.
SEC Form D · Jan 2015
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
10 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| A.M. Pappas & Associates, LLC | Other | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| A.M. Pappas Life Science Ventures III, L.P. | Venture capital | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| Care Capital III LLC | Fund or asset manager | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| Care Capital Investments III L.P. | Fund or asset manager | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| Care Capital Offshore Investments III LP | Fund or asset manager | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| Domain Partners VI, L.P. | Fund or asset manager | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| DP VI Associates, L.P. | Fund or asset manager | not stated | not stated | Held Series A and B preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| Novo Holdings A/s | Fund or asset manager | not stated | not stated | Held Series C preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| PV III CEO Fund, L.P. | Fund or asset manager | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| TVM Life Science Ventures VII L.P. | Venture capital | not stated | not stated | Held Series C preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 11 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Arthur M. Pappas | Executive officer | Jan 2015 |
| Bernice C. Kuca | Executive officer | Jan 2015 |
| Mathers P. Thomas | Executive officer | Jan 2015 |
| Nadia C. Rupniak | Executive officer | Jan 2015 |
| Timothy C. Gupton | Executive officer | Jan 2015 |
| Arthur M Pappas | Executive officer | Jan 2010 |
| Daniel L Boeglin | Executive officer | Jan 2010 |
| James F White | Executive officer | Jan 2010 |
| Nadia C Rupniak | Executive officer | Jan 2010 |
| Timothy C Gupton | Executive officer | Jan 2010 |
| Arthur M. Pappas | Director | Jan 2015 |
| Jesse I. Treu | Director | Jan 2015 |
| Luc C. Marengere | Director | Jan 2015 |
| Martin C. Edwards | Director | Jan 2015 |
| Mathers P. Thomas | Director | Jan 2015 |
| Richard J. Markham | Director | Jan 2015 |
| Arthur M Pappas | Director | Jan 2010 |
| James F White | Director | Jan 2010 |
| Jesse I Treu | Director | Jan 2010 |
| Richard I Markham | Director | Jan 2010 |